Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· The Science of WellnessAudio: English

Zombie Cells: The First Human Results Are In

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

Scientists call them zombie cells. The story says senolytics will extend life. Here is what the first human trials actually show. CHAPTERS 0:00 The Zombie-Cell Hook 0:46 What Is Senescence? 1:36 The SASP 2:12 Inflammaging 2:48 Lifespan Proof in Mice 3:28 A Trace of Cells Caused Frailty 4:32 First Human Proof 5:39 The First Randomized Trial 6:42 What Is Not Ready Yet 8:09 The Real Senolytic Is Exercise 9:03 The Honest Shape of the Field SOURCES Hayflick L, Moorhead PS. Exp Cell Res 1961 Coppe JP, et al. PLoS Biol 2008 Baker DJ, et al. Nature 2016 Xu M, et al. Nat Med 2018 Hickson LJ, et al. EBioMedicine 2019 Justice JN, et al. EBioMedicine 2019 Farr JN, et al. Nat Med 2024 Englund DA, et al. Aging Cell 2021 DISCLAIMER: This video is for educational purposes only. No senolytic drug is approved for aging. Dasatinib is a prescription chemotherapy drug with serious risks. Do not self-administer. Subscribe to The Science of Wellness for evidence-based mini-documentaries.

The Science of Wellness · 10 min · Source published: 2026-08-25

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…